Benzinga | Mar 2, 2021 07:32AM EST

TG Therapeutics Q4 EPS $(0.71) Misses $(0.58) Estimate, Sales $38.00K Inline

TG Therapeutics (NASDAQ:TGTX) reported quarterly losses of $(0.71) per share which missed the analyst consensus estimate of $(0.58) by 22.41 percent. This is a 61.36 percent decrease over losses of $(0.44) per share from the same period last year. The company reported quarterly sales of $38.00 thousand which met the analyst consensus estimate. This is the same as the same period last year.